Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seoul Gangnam Wooridul Hospital is a world-leading medical institution specializing in the treatment of spinal and joint disorders, particularly through minimally invasive surgical techniques. Established as a flagship of the Wooridul Hospital Group, it is renowned for developing and refining the Minimally Invasive Spine Surgery & Technique (MISST), which prioritizes the preservation of natural spinal structures. The hospital offers comprehensive care across neurosurgery, orthopedics, and rehabilitation medicine, treating conditions such as herniated discs, spinal stenosis, and scoliosis. It serves as a global hub for medical tourism and physician training, attracting patients and surgeons from around the world. The facility is equipped with advanced diagnostic and surgical technologies, including endoscopic and laser-assisted systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seoul Gangnam Wooridul Hospital.